Home › Funds › NEA Management Company, LLC › MBX
NEA Management Company, LLC position in MBX
MBX BIOSCIENCES INC COM · Health Care
NEA Management Company, LLC reported holding 3,614,486 shares of MBX (MBX BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$199.5M, representing 12.56% of its reported portfolio and ranking #2 among its reported holdings. NEA Management Company, LLC has disclosed MBX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How NEA Management Company, LLC's MBX position evolved
NEA Management Company, LLC first disclosed a stake in MBX in Q3 2024 at 3,614,486 shares (US$93.9M). The position peaked in Q2 2026 at 3,614,486 shares, worth US$199.5M. Across 8 filings, NEA Management Company, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,614,486 shares valued at US$199.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 3.61M | $93.90M | New |
| Q4 2024 | 3.61M | $66.61M | Hold |
| Q1 2025 | 3.61M | $26.67M | Hold |
| Q2 2025 | 3.61M | $41.24M | Hold |
| Q3 2025 | 3.61M | $63.25M | Hold |
| Q4 2025 | 3.61M | $114.00M | Hold |
| Q1 2026 | 3.61M | $107.89M | Hold |
| Q2 2026 | 3.61M | $199.52M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MBX and 13F data
MBX (MBX BIOSCIENCES INC COM) is a Health Care company. 73 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), ORBIMED ADVISORS LLC (US$189.3M), Paradigm Biocapital Advisors LP (US$138.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MBX
- Frazier Life Sciences Management, L.P. 6.65M sh · $367.19M · Q2 2026
- ORBIMED ADVISORS LLC 3.43M sh · $189.27M · Q2 2026
- Paradigm Biocapital Advisors LP 2.51M sh · $138.44M · Q2 2026
- NVP Associates, LLC 2.14M sh · $117.93M · Q2 2026
- Deep Track Capital, LP 1.73M sh · $95.64M · Q2 2026
- Aaron Wealth Advisors LLC 1.18M sh · $68.92M · Q3 2026
- Kynam Capital Management, LP 934.80K sh · $51.60M · Q2 2026
- Parkman Healthcare Partners LLC 800.17K sh · $44.17M · Q2 2026
- BRAIDWELL LP 710.88K sh · $39.24M · Q2 2026
- TCG Crossover Management, LLC 650.00K sh · $35.88M · Q2 2026
- Cormorant Asset Management, LP 550.00K sh · $30.36M · Q2 2026
- Soleus Capital Management, L.P. 515.28K sh · $28.44M · Q2 2026
More on NEA Management Company, LLC
FAQ
How long has NEA Management Company, LLC held MBX?
NEA Management Company, LLC has disclosed MBX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is NEA Management Company, LLC's current position in MBX?
As of Q2 2026, NEA Management Company, LLC holds 3.61M shares of MBX (MBX BIOSCIENCES INC COM), valued at $199.52M, representing 12.56% of its reported portfolio and ranking #2.
Has NEA Management Company, LLC been buying or selling MBX?
In the latest 13F filing (Q2 2026), NEA Management Company, LLC held unchanged its position in MBX. The position peaked in Q2 2026 at 3.61M shares.
Which other funds hold MBX?
Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.